Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study of the Efficacy of 18F-FSPG PET/CT in Subjects With Intracranial Cancers

NCT02370563 is registered in ClinicalTrials.gov with Lantheus Biosciences Ltd. as lead sponsor.

NCT NCT02370563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02370563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study of the Efficacy of 18F-FSPG PET/CT in Subjects With Intracranial Cancers
Lead sponsor
Lantheus Biosciences Ltd.
Phase
Phase 1
Overall status
Terminated
Start date
November 30, 2014
Completion date
March 31, 2016
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain cancer